Strides Shasun has reported results for first quarter ended June 30, 2016.
The company has registered 87.32% growth in its net profit at Rs 27.18 crore for the quarter as compared to Rs 14.51 crore for the same quarter in the previous year. Total Income of the company increased by 41.32% to Rs 549.47 crore for quarter under review from Rs 525.01 crore for the quarter ended June 30, 2015.
On the consolidated basis, the company has reported over one fold jump in its net profit after taxes, minority interest and share of profit of associates at Rs 26.04 crore for the quarter ended June 30, 2016 as compared to Rs 10.62 crore for the same quarter in the previous year. However, total Income of the company increased by 41.32% to Rs 907.66 crore for quarter under review from Rs 642.26 crore for the quarter ended June 30, 2015.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: